 Home > Biochemistry News > Biotechnology News > Improve targeted therapy for movement disorders

Improve targeted therapy for movement disorders

 Last Update: 2022-04-19
 Source: Internet
 Author: User

Tags

2.5 fraction form

people survived hindenburg

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Image: In patients with cervical dystonia, symptom improvement is associated with stimulation of the blue tract; in patients with generalized dystonia, with stimulation of the yellow tract

Source: Charité | Andreas Horn

The recent findings of researchers from Charité - Universitätsmedizin Berlin may be crucial for improving the treatment of dystonia, a neuromotor disorder

Dystonia is a rare neurological disorder characterized by involuntary, twisted, and twisted movements and postures

One treatment for people with dystonia is neurosurgery, in which electrodes are implanted in specific areas of the brain

"The precise degree to which this stimulation responds to the symptoms of different types of dystonia was not known until now," says Dr.

Professor Kühn's team studied 80 patients who had been treated for generalized dystonia or cervical dystonia in one of five different hospitals in Germany and Austria

A key finding was that the optimal target for stimulation depends on the type of dystonia being treated

"Our study showed clear differences in the optimal stimulation site, which corresponds to the somatic structure of the medial pallidum

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.